What's breaking now, across thousands of outlets.
For $550 million up front, Argenx will take control of Unnatural Products’ “macrocyclic peptide” technology and direct it to develop oral, durable medicines for serious immune-mediated diseases.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Budi Sadikin, Indonesia’s Minister of Health and the country’s nominee for WHO Director General, has in fact spent most of his career in finance – as a top executive at Indonesia’s largest bank, PT…
Pakistani actress Meera’s younger sister, Shaista Abbas, has died in London after battling cancer. Meera confirmed her sister’s death while … Read More The post Meera’s Sister Dies in London After…
Delix Therapeutics has raised $100 million in a Series C to catch up to a budding crop of psychedelics and neuroplastogen drugmakers, cashing in on a new wave of medicines for psychiatric and mental…
WASHINGTON — Former U.S. president Joe Biden says he is scaling back plans to promote his upcoming memoir as he battles aggressive prostate cancer, acknowledging that the illness sometimes leaves him struggling.
